CDIO

NASDAQ · Biotechnology

Cardio Diagnostics Holdings

Penny Stocks Biotech Stocks Healthcare Stocks

$2.01

-0.15 (-6.94%)

CDIO News1 articles

Novo Nordisk Shares Plunge 9% as ZEUS Trial Fails to Show Cardiovascular Benefit

Novo Nordisk shares fell sharply after ZEUS trial data showed no significant cardiovascular benefit, wiping out $20.5 billion in market cap and underscoring heavy reliance on GLP-1 franchise.